iAssay® Continues to Innovate and Take Interoperability in Healthcare to New Heights

For Release March 2, 2022 iAssay® Continues to Innovate and Take Interoperability in Healthcare to New Heights San Diego— March 2, 2022— iAssay has developed devices for the healthcare industry that already exceed the capabilities of currently available diagnostic readers. In addition, incorporating seamless connectivity to secure data servers ensures that data collected will conform […]

iAssay, Inc. Joins MetroConnect to Accelerate International Growth

iAssay, Inc. joins MetroConnect to accelerate international growth Export assistance program to support iAssay, Inc. with growth in European and Asian medical diagnostics markets San Diego – Today, iAssay, Inc. has been named as one of 15 San Diego companies participating in MetroConnect, World Trade Center San Diego (WTCSD)’s comprehensive export assistance program that helps […]

iAssay Receives Notice of Allowance for New U.S. Patent for Universal Portable Assay Device

SAN DIEGO, CA – January 4, 2022 – iAssay® Inc., a privately held developer of the world’s first open platform, point of care (POC) reader for remote medical diagnostics, announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Patent Application 17/001,069. The allowed patent includes […]

iAssay Business Accelerates

This is the last opportunity to get out a team recap before this this exciting year ends. iAssay’s best year ever for sure. Here are the major highlights for the year: Wan Kuo joined the company as our Buyer/Planner, and she is setting up the Purchasing function at iAssay. We are moving from an Excel-based/manual […]

iAssay Dramatically Expands Headquarters

We are growing! iAssay is proud to announce we have dramatically expanded our base of operations. Our new space is 4 times larger, and now includes a dry lab area. While we continue to work on our next generation models, our new facility will allow us to keep up with current demand. We’d love to […]

iAssay Hires Wan J Kuo to Lead its Procurement Activities

iAssay is growing! Wan Kuo has joined us as our Buyer / Planner. As a result of new business, Wan will be handling the increasing day-to-day responsibilities for purchasing, and inventory control. She is planning for the future, and is in fact making recommendations for the implementation of a mini-ERP system. Wan will leverage her nearly 2 decades of […]

Strong Presentation at AFWERX Collider Event

As previously announced, iAssay recently participated in the AFWERX Collider event. Scientific Director Ed Strong described how iAssay’s CyberReader can support military medical and environmental diagnostics needs. His presentation was well attended. Here is the link to a recording of his presentation: iAssay specifically seeks an Air Force partner for a Phase II SBIR who is […]

iAssay to Present at Collider Event on August 31, 2021 at 12:02 PM EDST

As an Air Force SBIR I contract receipient, iAssay was chosen to present its exciting SimpleTest 2 Point of Care Medical Diagnostics technology during the Collider’s Human / Wearable / Health / Genetics section on August 31, 2021 at 12:02 PM EDST. Please see the attached announcement for further information on the event this week! […]

Startups Cash In as Venture Funding for Digital Health Rises

iAssay has benefitted from this trend as predicted years ago. Our equity raise and increasing revenues prove it. The whole story from The Wall Street Journal– Increasing venture-capital investment in digital health is helping startups accelerate their growth while also raising concerns that the market is overheating. Venture investors pumped $14.7 billion into digital-health startups […]